Toyobo Co., Ltd.

Toyobo Co., Ltd.

TYOBY
Toyobo Co., Ltd.US flagOther OTC
10.70
USD
- -
- -
944.22MMarket Cap
Toyobo Co., Ltd.
TYOBY
(Other OTC)

Recent

price

10.70

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
4,388.66
4,496.36
3,941.82
3,822.16
3,956.77
3,956.51
3,917.06
3,711.32
3,730.24
3,793.01
3,824.66
3,798.16
4,227.46
4,499.31
4,702.88
4,789.21
2,438.94
Revenue per Share
28.83
54.86
51.73
86.13
91.77
91.42
114.33
106.38
146.93
-6.79
155.12
47.3
144.75
-7.37
27.87
22.73
5.04
Basic EPS, GAAP
200.93
259.56
-27.82
156.48
40.3
24.31
173.22
109.49
18.69
-184.72
150.88
84.8
-135.19
-352.82
-397.72
-171.43
- -
Free Cash Flow per Basic Share
33.63
34.38
34.9
34.91
35
35.08
35.04
35.05
35.04
39.99
39.99
39.96
39.98
40
40.09
40
- -
Dividend per Share
787.8
887.34
775.63
826.4
879.58
948.46
1,028.03
1,099.91
1,214.85
1,166.95
1,280.03
1,306.72
1,422.54
1,375.04
1,385.5
1,369.67
1,347.31
Book Value per Share
1,782.79
1,952.64
1,647.97
1,739.43
1,599.1
1,777.05
1,759.84
1,877.97
2,033.59
2,000.41
2,004.58
2,070.84
2,169.79
2,438.99
2,559
2,576.13
2,542.99
Tangible Book Value per Share
73
76
89
89
89
89
89
89
89
89
89
89
89
89
88
88
88
Basic Weighted Avg Shares
318,773
340,573
349,505
339,009
351,577
351,279
347,763
329,487
331,148
336,698
339,607
337,406
375,720
399,921
414,265
422,032
214,846
Sales/Revenue/Turnover
3.6
6.13
5.24
5.04
5.97
5.86
6.65
7.08
7.22
6.45
6.71
7.9
7.57
2.52
2.17
3.95
3.09
Operating Margin (%)
19,474
19,113
19,473
13,246
14,038
14,916
14,434
14,939
15,666
15,823
17,005
19,095
20,080
19,050
19,806
22,698
- -
Depreciation Expense
2,094
4,155
4,587
7,639
8,154
8,117
10,150
9,444
13,044
-603
13,774
4,202
12,865
-655
2,455
2,003
444
Net Income, GAAP
- -
- -
47.33
34.43
34.03
32.67
36.72
35.24
28.76
895.1
32.49
58.58
18.48
231.86
35.92
27.47
19.51
Effective Tax Rate (%)
0.66
1.22
1.31
2.25
2.32
2.31
2.92
2.87
3.94
-0.18
4.06
1.25
3.42
-0.16
0.59
0.47
0.21
Profit Margin (%)
-6,225
8,557
14,885
19,908
24,048
50,357
55,943
59,428
61,461
61,357
84,095
81,519
92,564
96,633
89,585
107,175
103,337
Working Capital
84,460
73,247
69,833
72,278
90,831
110,425
103,697
95,440
88,188
99,009
130,851
122,046
125,681
114,099
145,637
181,343
175,192
LT Debt
131,097
149,773
147,725
155,522
145,116
161,086
160,102
170,910
184,515
181,226
182,636
188,635
197,149
221,423
230,086
232,044
228,869
Total Equity
- -
- -
3.22
3.68
4.44
4.26
4.42
4.55
5.1
-51.27
4.41
3.04
6.13
-3.19
1.25
2.5
1.17
Return on Invested Capital (%)
- -
- -
1.9
3.38
3.31
3.57
4.24
4.08
5.33
-4.08
5.4
2.24
4.74
-0.65
0.57
0.1
-0.14
Return on Capital (%)
3.67
6.68
6.75
10.75
10.77
10
11.57
10
12.7
-0.57
12.68
3.66
10.61
-0.53
2.01
1.65
0.37
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Mar'24
Jun'25
Sep'25
ST Debt
96,454
- -
74,344
LT Borrowings
145,637
- -
175,192
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
88
- -
88
Market Capitalization
- -
- -
85,798

Working Capital

FRC

in mil. unless spec.
Mar'24
Jun'25
Sep'25
Total Current Assets
273,733
- -
257,300
Cash, Cash Equivalents & STI
33,796
- -
28,353
Accounts Receivable, Net
87,743
- -
82,498
Inventories
121,983
- -
119,970
Total Current Liabilities
184,148
- -
153,963
Payables & Accruals
- -
- -
- -
ST Debt
96,454
- -
74,344
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
3.8%
4.97%
0.85%
Free Cash Flow
-96.46%
-37.48%
-56.88%
Net Income, GAAP
-289.43%
-92.33%
-18.41%
Sales/Revenue/Turnover
1.94%
4.52%
1.87%
Total Cash Common Dividend
1.33%
-0.15%
-0.17%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
97,058
102,361
107,904
106,942
414,265
2025
- -
- -
- -
- -
422,032
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-5.77
- -
- -
- -
27.87
2025
- -
- -
- -
- -
22.73
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
40.09
2025
- -
- -
- -
- -
40
2026
- -
- -
- -
- -
- -
Business
Toyobo Co., Ltd. manufactures, processes, and sells advanced materials including films, life science products, environmental and functional materials, and functional textiles worldwide. The company offers packaging films and industrial films such as PET films for liquid crystal displays, optical uses, and synthetic papers; biopharmaceutical products including diagnostic enzymes, pharmaceuticals, medical membranes, hollow fiber membranes for artificial kidneys, and medical tools like nerve regeneration conduits (Nerbridge) and bone regeneration materials (Bonarc); engineering plastics, automotive functional materials, industrial adhesives (VYLON, HARDLEN), photo-functional materials, high-performance fibers, functional filters, nonwoven fabrics (VOLANS), aqua membranes, and airbags; as well as real estate leasing and other businesses. Toyobo operates primarily in Japan, Asia, North America, Europe, and Latin America, targeting industries such as electronics, automotive, healthcare, packaging, and environmental solutions. Founded in 1882 and headquartered in Osaka Umeda Twin Towers South, 1-13-1 Umeda, Kita-ku, Osaka, Japan, the company employs around 9,976 people on a consolidated basis. Recent developments include the establishment of Toyobo MC Corporation as a joint venture with Mitsubishi Corporation in 2023 for functional materials; a June 2025 joint development agreement with DMC Biotechnologies Inc. for sustainable plastic raw materials; an August 2025 company split transferring resin business to Toyobo MC effective October 2025; plans to boost COSMOSHINE SRF film production by 30% at Tsuruga Plant starting fiscal 2026; and a November 2025 absorption-type merger of wholly owned subsidiary TOYOBO STC Co., Ltd. effective April 2026 to streamline trading operations.